Understanding Oncology and Use of Rapamycin as an Anti-Aging Drug from Mikhail Blagosklonny

Stimulating Immunity Through the Use of an Anti-Aging Drugs

Most people believe that aging comes as an indication of the functional decline of a person and is brought about by the concentration of some random molecular damage that can never be prevented. So as to break this belief, a hyperfunction theory has been established, and it explains aging as a form of continuous growth compelled through some signal pathways. These pathways include the Target of Rapamycin (TOR), and TOR centric prototype helps to predict that rapalogs can be used to prevent illnesses or treat aging in human beings. Apparently, this theory was criticized by opponents who were then put to the test through the TOR centric prototype, and it was stated that in five years they would not believe in the model. As a matter of fact, this prediction was proven to be the truth after five years. Here is an in-depth analysis of Rapamycin as an anti-aging drug:

To understand oncology, one can review the life and career of Mikhail Blagosklonny who has a vast knowledge of the profession. He has been working at Roswell Park Cancer Institute as a professor of oncology and is also a scientist currently studying aging and cancer. He has earned himself different certification from various medical institutions such as MD in Internal Medicine and Ph.D. in Experimental Medicine and Cardiology from First Pavlov State Medical University among others. He has also worked in different institutions where in combination with knowledge learned in school and work he has been able to gain vast experience and skills in his profession. Most of the research topic that he has concentrated on in most cases is in biogerontology, anti-aging drugs, and cancer. Here is a portion of information written according to his research on anti-aging drugs. View Mikhail’s profile in LinkedIn

Rapamycin in today’s medical field is believed to improve the immunity of an aging person, and this has been proven by a study carried on Everolimus which is a form of rapamycin analog. More research conducted by Novartis Working based on Fountain of Youth drug also concluded that the drug could be used to delay most the effects brought about by aging. They also said that it could help to enhance the health of elderly adults. In conclusion, Nir Barzilai said that the researchers only need to set the stage in which the drug can be used by the patients to bring better results about aging.

In previous years, it has also been proven that Rapamune or Sirolimus scientifically known as rapamycin is suitable for clinical uses. It not only helps to treat cardiovascular diseases, cancer, metabolic disorders and autoimmunity but also can treat all aging disorders such as Alzheimer’s or osteoporosis. The drug is more beneficial when used as an anti-aging drug so as to help in delaying senescence and also prevent aging diseases. Rapamycin can be very helpful if health practitioners can be administering it to transplant patients on a daily basis. This is because it has been proven safe to transform the immunity of older adults to that of an infant. In other words, rapamycin helps a lot in rejuvenating immunity. Visit ResearchGate.Net to learn more about Mikhail’s latest work.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>